Newswriter.ai

Curated Business & Technology News from Around the Internet

Lantern Pharma Receives FDA Guidance for Pediatric Brain Cancer Therapy Trial FEATURED

Lantern Pharma Receives FDA Guidance for Pediatric Brain Cancer Therapy Trial

Lantern Pharma has secured FDA regulatory guidance to advance its LP-184/STAR-001 therapy toward clinical trials for rare pediatric central nervous system cancers, representing a significant step in …
Source September 30, 2025
Read More

Showing 28 of 4036 articles (Page 45 of 145)